Fox Run Management, L.L.C. Becton Dickinson & CO Transaction History

Fox Run Management, L.L.C.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$225.07 - $246.17 $690,514 - $755,249	3,068 New	3,068 $717,000
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $294,944 - $339,382	1,270 New	1,270 $309,000
Q4 2022 Feb 07, 2023	BUY	$218.29 - $256.91 $185,328 - $218,116	849 Added 65.26%	2,150 $546,000
Q3 2022 Nov 07, 2022	BUY	$51.03 - $264.23 $66,390 - $343,763	1,301 New	1,301 $290,000
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $721,590 - $846,641	-3,074 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$243.64 - $270.48 $748,949 - $831,455	3,074 New	3,074 $818,000
Q4 2021 Feb 09, 2022	SELL	$230.08 - $250.94 $326,023 - $355,581	-1,417 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $329,764 - $363,417	1,417 New	1,417 $348,000
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $204,703 - $226,568	-882 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$221.92 - $245.94 $195,733 - $216,919	882 New	882 $221,000
Q1 2019 Oct 17, 2019	SELL	$206.05 - $248.17 $467,115 - $562,601	-2,267 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$204.73 - $257.93 $266,967 - $336,340	1,304 Added 135.41%	2,267 $511,000
Q3 2018 Oct 05, 2018	BUY	$233.07 - $256.0 $224,446 - $246,528	963 New	963 $251,000
Q2 2018 Jul 17, 2018	SELL	$208.1 - $233.85 $580,599 - $652,441	-2,790 Closed	0 $0
Q1 2018 Apr 17, 2018	SELL	$205.46 - $240.27 $156,765 - $183,326	-763 Reduced 21.47%	2,790 $605,000
Q4 2017 Jan 18, 2018	BUY	$189.0 - $222.64 $671,517 - $791,039	3,553	3,553 $761,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.